COMMUNIQUÉS West-GlobeNewswire

Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus
28/07/2026
Bemnifosbuvir/Ruzasvir (BEM/RZR) Achieved its Primary Endpoint of Statistical Non-inferiority Compared to Sofosbuvir/Velpatasvir (SOF/VEL; Epclusa ® ), a Standard-of-Care, in First-Ever Successful Head-to-Head Trial in [...]
Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026
28/07/2026
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will report its second [...]
Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
28/07/2026
Second quarter revenue of $204 million, a year-over-year increase of 12% as reported and 13% organic GAAP operating income increased 1% year-over-year while adjusted operating income increased 55% Raising both FY26 [...]
Antag Therapeutics Announces Dosing of First Patient in Phase 2a Trial of First-in-Class GIPR Antagonist AT7687
28/07/2026
The Phase 2a study will evaluate AT7687 as a differentiated combination treatment approach for people living with obesity and type 2 diabetes A 13-week study of 150 randomized participants receiving either once-weekly [...]
Transactions in connection with share buy-back program
28/07/2026
Company announcement no. 27 - 26 28 July 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC
28/07/2026
Promatix Biosciences Awarded Innovate UK Biomedical Catalyst Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC Non-dilutive Biomedical Catalyst funding from Innovate UK will support the advancement of [...]
Xeltis raises an additional €20.5m of funding to advance aXess™ toward FDA approval and US commercial launch
28/07/2026
New investor Horizon 3 Healthcare led the round, which was supported by the European Innovation Council, Invest-NL, VI Partners, EQT Life Sciences, DaVita and other current shareholders Builds on the €50m secured in [...]
Aqua free Supports Drinking Water Project in Tanzania
28/07/2026
Hamburg, 28.07.2026 - Access to safe water is still not given in many parts of the world. In Lower Moshi, a region south of Mount Kilimanjaro in Tanzania, communities and schools struggle with contaminated drinking [...]
Aqua free soutient un projet d’accès à l’eau potable en Tanzanie
28/07/2026
Hamburg, 28.07.2026 - Dans de nombreuses régions du monde, l’accès à une eau potable sûre est encore loin d’être garanti. Dans le Lower Moshi, une région située au sud du Kilimandjaro, en Tanzanie, les communautés [...]
Tensive reports pivotal 12-month clinical trial data confirming REGENERA™ delivers natural breast reconstruction after lumpectomy
28/07/2026
Good-to-excellent cosmetic outcomes 30 of 94 patients enrolled have now reached 24 months of follow-up High surgeon satisfaction sustained through study to date Improvements in patient-reported breast satisfaction and [...]
Rapid Nutrition Expands Owned-Brand Portfolio Through AI-Driven Commercial Intelligence
28/07/2026
Initial rollout of the Premium Nutrition Pantry demonstrates the Company's strategy to accelerate owned-brand expansion, strengthen vertical integration and support long-term revenue growth LONDON, July 28, 2026 (GLOBE [...]
ARCPOINT PROVIDES UPDATE ON MANAGEMENT CEASE TRADE ORDER APPLICATION AND DELAY IN FILING ANNUAL FINANCIAL STATEMENTS
28/07/2026
GREENVILLE, South Carolina, July 27, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) provides an update further to its news release dated July 15, 2026 (the “ MCTO Application [...]
BurnTide Launch 2026: New Weight Loss Support ACV Gummies In The USA, AU, UK | Burntide Supplement Facts And Highlights Ingredients.
28/07/2026
Burntide is announcing an effective and updated weight loss support supplement, Burntide Gummies, analyzing the natural ingredient profile, supplement facts, manufacturing information, Customer Service Support Details, [...]
CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology
28/07/2026
Data reinforce durable responses, bladder preservation, low rate of disease progression, and favorable safety and tolerability in patients with high-risk, BCG-unresponsive non-muscle invasive bladder cancer DALLAS, July [...]
Legacy Health Works LLC Announces Kylar Denae Williams, 2024 University of Arkansas Graduate, as Chief Executive Officer of the Family-Built, AI-Infused Healthcare Company
28/07/2026
From graduation cap to CEO in two years: Williams, who earned her Bachelor of Science in Human Development and Family Science in 2024, leads the Dallas-based one-stop healthcare workforce development and communication [...]
Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026
27/07/2026
-First scientific presentation of the Emperor Drive System architecture to the biomedical engineering community- TUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) ("Picard" or [...]
STERIS to Host a Conference Call for Fiscal 2027 First Quarter on August 6, 2026
27/07/2026
DUBLIN, IRELAND, July 27, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2027 first quarter results at 9:00 a.m. ET [...]
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy
27/07/2026
Management Met with Potential Acquisition, Licensing, Joint Venture, and Commercial Partners Across the Region Initiative Aims to Expand Mission of Saving Lives Through Early Detection and Prevention of Cancers and [...]
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
27/07/2026
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 Mont-Saint-Guibert, Belgium – July 27, 2026, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), [...]

Pages